IBDEI1UK ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,32521,1,4,0)
 ;;=4^N20.2
 ;;^UTILITY(U,$J,358.3,32521,2)
 ;;=^5015609
 ;;^UTILITY(U,$J,358.3,32522,0)
 ;;=N20.0^^182^1988^7
 ;;^UTILITY(U,$J,358.3,32522,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32522,1,3,0)
 ;;=3^Calculus Kidney
 ;;^UTILITY(U,$J,358.3,32522,1,4,0)
 ;;=4^N20.0
 ;;^UTILITY(U,$J,358.3,32522,2)
 ;;=^67056
 ;;^UTILITY(U,$J,358.3,32523,0)
 ;;=N29.^^182^1988^56
 ;;^UTILITY(U,$J,358.3,32523,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32523,1,3,0)
 ;;=3^Kidney & Ureter Disorders in Diseases Classified Elsewhere
 ;;^UTILITY(U,$J,358.3,32523,1,4,0)
 ;;=4^N29.
 ;;^UTILITY(U,$J,358.3,32523,2)
 ;;=^5015631
 ;;^UTILITY(U,$J,358.3,32524,0)
 ;;=N28.9^^182^1988^55
 ;;^UTILITY(U,$J,358.3,32524,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32524,1,3,0)
 ;;=3^Kidney & Ureter Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,32524,1,4,0)
 ;;=4^N28.9
 ;;^UTILITY(U,$J,358.3,32524,2)
 ;;=^5015630
 ;;^UTILITY(U,$J,358.3,32525,0)
 ;;=N30.01^^182^1988^18
 ;;^UTILITY(U,$J,358.3,32525,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32525,1,3,0)
 ;;=3^Cystitis w/ Hematuria,Acute
 ;;^UTILITY(U,$J,358.3,32525,1,4,0)
 ;;=4^N30.01
 ;;^UTILITY(U,$J,358.3,32525,2)
 ;;=^5015633
 ;;^UTILITY(U,$J,358.3,32526,0)
 ;;=N30.00^^182^1988^20
 ;;^UTILITY(U,$J,358.3,32526,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32526,1,3,0)
 ;;=3^Cystitis w/o Hematuria,Acute
 ;;^UTILITY(U,$J,358.3,32526,1,4,0)
 ;;=4^N30.00
 ;;^UTILITY(U,$J,358.3,32526,2)
 ;;=^5015632
 ;;^UTILITY(U,$J,358.3,32527,0)
 ;;=N30.41^^182^1988^19
 ;;^UTILITY(U,$J,358.3,32527,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32527,1,3,0)
 ;;=3^Cystitis w/ Hematuria,Irradiation
 ;;^UTILITY(U,$J,358.3,32527,1,4,0)
 ;;=4^N30.41
 ;;^UTILITY(U,$J,358.3,32527,2)
 ;;=^5015640
 ;;^UTILITY(U,$J,358.3,32528,0)
 ;;=N30.40^^182^1988^21
 ;;^UTILITY(U,$J,358.3,32528,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32528,1,3,0)
 ;;=3^Cystitis w/o Hematuria,Irradiation
 ;;^UTILITY(U,$J,358.3,32528,1,4,0)
 ;;=4^N30.40
 ;;^UTILITY(U,$J,358.3,32528,2)
 ;;=^5015639
 ;;^UTILITY(U,$J,358.3,32529,0)
 ;;=N32.0^^182^1988^6
 ;;^UTILITY(U,$J,358.3,32529,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32529,1,3,0)
 ;;=3^Bladder-Neck Obstruction
 ;;^UTILITY(U,$J,358.3,32529,1,4,0)
 ;;=4^N32.0
 ;;^UTILITY(U,$J,358.3,32529,2)
 ;;=^5015649
 ;;^UTILITY(U,$J,358.3,32530,0)
 ;;=N31.9^^182^1988^69
 ;;^UTILITY(U,$J,358.3,32530,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32530,1,3,0)
 ;;=3^Neuromuscular Dysfunction of Bladder,Unspec
 ;;^UTILITY(U,$J,358.3,32530,1,4,0)
 ;;=4^N31.9
 ;;^UTILITY(U,$J,358.3,32530,2)
 ;;=^5015648
 ;;^UTILITY(U,$J,358.3,32531,0)
 ;;=N31.1^^182^1988^70
 ;;^UTILITY(U,$J,358.3,32531,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32531,1,3,0)
 ;;=3^Neuropathic Bladder,Reflex NEC
 ;;^UTILITY(U,$J,358.3,32531,1,4,0)
 ;;=4^N31.1
 ;;^UTILITY(U,$J,358.3,32531,2)
 ;;=^5015645
 ;;^UTILITY(U,$J,358.3,32532,0)
 ;;=N32.89^^182^1988^5
 ;;^UTILITY(U,$J,358.3,32532,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32532,1,3,0)
 ;;=3^Bladder Disorders,Other Spec
 ;;^UTILITY(U,$J,358.3,32532,1,4,0)
 ;;=4^N32.89
 ;;^UTILITY(U,$J,358.3,32532,2)
 ;;=^87989
 ;;^UTILITY(U,$J,358.3,32533,0)
 ;;=N33.^^182^1988^4
 ;;^UTILITY(U,$J,358.3,32533,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32533,1,3,0)
 ;;=3^Bladder Disorders,Diseases Classified Elsewhere
 ;;^UTILITY(U,$J,358.3,32533,1,4,0)
 ;;=4^N33.
 ;;^UTILITY(U,$J,358.3,32533,2)
 ;;=^5015654
 ;;^UTILITY(U,$J,358.3,32534,0)
 ;;=N34.2^^182^1988^95
 ;;^UTILITY(U,$J,358.3,32534,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,32534,1,3,0)
 ;;=3^Urethritis
 ;;^UTILITY(U,$J,358.3,32534,1,4,0)
 ;;=4^N34.2
 ;;
 ;;$END ROU IBDEI1UK
